Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor α-primed endodermal secretome

Stem Cells

Volumn 26, Issue 2, 2008, Pages 387-400

  Arrell, D Kent ^a   Niederländer, Nicolas J ^a   Faustino, Randolph S ^a   Behfar, Atta ^a   Terzic, Andre ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cardiopoiesis; Embryonic stem cell; Endoderm; Multidimensional liquid chromatography tandem mass spectrometry; Network biology; Proteomics; Secretome; Systems biology; Two dimensional gel electrophoresis

Indexed keywords

PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALGORITHM; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL FUNCTION; CHROMATOGRAPHY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDODERM; FOURIER TRANSFORM MASS SPECTROMETRY; HEART DEVELOPMENT; ION TRAP MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDE MAPPING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMIC CARTOGRAPHY; PROTEOMICS; SARCOMERE; SCREENING; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; ENDODERM; FETAL HEART; MICE; PROTEIN INTERACTION MAPPING; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949164677     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0599     Document Type: Article

References (88)

1. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature 2000;407:221-226.
2. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
3. Foley A, Mercola M. Heart induction: Embryology to cardiomyocyte regeneration. Trends Cardiovasc Med 2004;14:121-125.
4. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science 2006;313:1922-1927.
5. Schultheiss TM, Xydas S, Lassar AB. Induction of avian cardiac myogenesis by anterior endoderm. Development 1995;121:4203-4214.
6. Olson EN, Srivastava D. Molecular pathways controlling heart development. Science 1996;272:671-676.
7. Lough J, Sugi Y. Endoderm and heart development. Dev Dyn 2000;217:327-342.
8. Harvey RP. Patterning the vertebrate heart. Nat Rev Genet 2002;3:544-556.
9. Lin Q, Schwarz J, Bucana C et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997;276:1404-1407.
10. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006;127:1101-1104.
11. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
12. Smith AG. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 2001;17:435-462.
13. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-2740.
14. Behfar A, Perez-Terzic C, Faustino RS et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 2007;204:405-420.
15. Hodgson DM, Behfar A, Zingman LV et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004;287:H471-H479.
16. Tjalsma H, Bolhuis A, Jongbloed JDH et al. Signal peptide-dependent protein transport in Bacillus subtilis: A genome-based survey of the secretome. Microbiol Mol Biol Rev 2000;64:515-547.
17. Walter P, Gilmore R, Blobel G. Protein translocation across the endoplasmic reticulum. Cell 1984;38:5-8.
18. Mellman I, Warren G. The road taken: Past and future foundations of membrane traffic. Cell 2000;100:99-112.
19. Nickel W. The mystery of nonclassic protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003;270:2109-2119.
20. Nickel W. Unconventional secretory routes: Direct protein export across the plasma membrane of mammalian cells. Traffic 2005;6:607-614.
21. Behfar A, Zingman LV, Hodgson DM et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002;16:1558-1566.
22. Perez-Terzic C, Behfar A, Mery A et al. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res 2003;92:444-452.
23. Chung S, Dzeja PP, Faustino RS et al. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007;4:S60-S67.
24. Arrell DK, Elliott ST, Kane LA et al. Proteomic analysis of pharmacological preconditioning. Novel protein targets converge to mitochondrial metabolism pathways. Circ Res 2006;99:706-714.
25. Perez-Terzic C, Faustino RS, Boorsma BJ et al. Stem cell transformation into cardiac phenotype guided by directed remodeling of nuclear transport machinery. Nat Clin Prac Cardiovasc Med 2007;4:S1-S9.
26. Link AJ, Eng J, Schieltz DM et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 1999;17:676-682.
27. Perkins DN, Pappin DJC, Creasy DM et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-3567.
28. Ducret A, Van Oostveen I, Eng JK et al. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry. Protein Sci 1998;7:706-719.
29. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007;4:207-214.
30. Nesvizhskii AI, Aebersold R. Interpretation of shotgun proteomic data: The protein inference problem. Mol Cell Proteomics 2005;4:1419-1440.
31. Bendtsen JD, Nielsen H, von Heijne G et al. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004;340:783-795.
32. Bendtsen JD, Jensen LJ, Blom N et al. Feature based prediction of non-classic and leaderless protein secretion. Protein Eng Des Sel 2004;17:349-356.
33. Shannon P, Markiel A, Ozier O et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504.
34. Barabási A-L, Albert R. Emergence of scaling in random networks. Science 1999;286:509-512.
35. Jeong H, Tombor B, Albert R et al. The large-scale organization of metabolic networks. Nature 2000;407:651-654.
36. Watts DJ, Strogatz SH. Collective dynamics of 'small-world' networks. Nature 1998;393:440-442.
37. Barabási A-L, Oltvai ZN. Network biology: Understanding the cell's functional organization. Nat Rev Genet 2004;5:101-113.
38. Anderson TW, Darling DA. Asymptotic theory of certain "goodness-of-fit" criteria based on stochastic processes. Ann Math Stat 1952;23:193-212.
39. Newman MEJ. The structure and function of complex networks. SIAM Rev 2003;45:167-256.
40. Bader A, Gruss A, Hollrigl A et al. Paracrine promotion of cardiomyogenesis in embryoid bodies by LIF modulated endoderm. Differentiation 2001;68:31-43.
41. Erdös P, Rényi A. On the evolution of random graphs. Publ Math Inst Hung Acad Sci 1960;5:17-61.
42. Corti S, Locatelli F, Donadoni C et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-2532.
43. Kobayashi-Miura M, Shioji K, Hoshino Y et al. Oxygen sensing and redox signalling: The role of thioredoxin in embryonic development and cardiac diseases. Am J Physiol Heart Circ Physiol 2007;292:H2040-H2050.
44. Tetzlaff MT, Yu W, Li M et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A 2004;101:3338-3345.
45. Ko JA, Kimura Y, Matsuura K et al. PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes. J Cell Sci 2006;119:5106-5113.
46. Goldring K, Jones GE, Thiagarajah R et al. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J Cell Sci 2002;115:355-366.
47. Chan J, O'Donoghue K, Gavina M et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. STEM CELLS 2006;24:1879-1891.
48. Plageman TF Jr, Yutzey KE. Microarray analysis of Tbx5-induced genes expressed in the developing heart. Dev Dyn 2006;235:2868-2880.
49. Bader BL, Smyth N, Nedbal S et al. Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 2005;25:6846-6856.
50. Costell M, Carmona R, Gustafsson E et al. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 2002;91:158-164.
51. Houston DS, Carson CW, Esmon CT. Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor release and augment neutrophil elastase release. J Biol Chem 1997;272:11778-11785.
52. Berger I, Bieniossek C, Schaffitzel C et al. Direct interaction of Ca2+/ calmodulin inhibits histone deacetylase 5 repressor core binding to myocyte enhancer factor 2. J Biol Chem 2003;278:17625-17635.
53. 2+ checkpoint in cardiac myofibrillogenesis. J Cell Biol 2002;158:103-113.
54. Lynch JM, Chilibeck K, Qui Y et al. Assembling pieces of the cardiac puzzle; calreticulin and calcium-dependent pathways in cardiac development, health, and disease. Trends Cardiovasc Med 2006;16:65-69.
55. Jin ZG, Melaragno MG, Liao DF et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000;87:789-796.
56. Hong F, Lee J, Song JW et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cistrans isomerase activity of cyclophilin A: Cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002;16:1633-1635.
57. Suzuki M, Takamura Y, Maeno M et al. Xenopus laevis macrophage migration inhibitory factor is essential for axis formation and neural development. J Biol Chem 2004;279:21406-21414.
58. Ge G, Greenspan DS. BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 2006;175:111-120.
59. Ge G, Greenspan DS. Developmental roles of the BMP1/TLD metalloproteinases. Birth Defects Res C Embryo Today 2006;78:47-68.
60. Aviezer D, Hecht D, Safran M et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994;79:1005-1013.
61. Ibrahimi OA, Zhang F, Hrstka SC et al. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 2004;43:4724-4730.
62. Albert R, Jeong H, Barabási A-L. Error and attack tolerance of complex networks. Nature 2000;406:378-382.
63. Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat Clin Pract Cardiovasc Med 2006;3:S78-S82.
64. Mbeunkui F, Fodstad O, Pannell LK. Secretory protein enrichment and analysis: An optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res 2006;5:899-906.
65. Klee EW, Ellis LB. Evaluating eukaryotic secreted protein prediction. BMC Bioinformatics 2005;6:256.
66. Tjalsma H, Antelmann H, Jongbloed JD et al. Proteomics of protein secretion by Bacillus subtilis: Separating the "secrets" of the secretome. Microbiol Mol Biol Rev 2004;68:207-233.
67. Grønborg M, Kristiansen TZ, Iwahori A et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006;5:157-171.
68. Pellitteri-Hahn MC, Warren MC, Didier DN et al. Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells. J Proteome Res 2006;5:2861-2864.
69. Khwaja FW, Svoboda P, Reed M et al. Proteomic identification of the wt-p53-regulated tumor cell secretome. Oncogene 2006;25:7650-7661.
70. Jeffery CJ. Moonlighting proteins: Old proteins learning new tricks. Trends Genet 2003;19:415-417.
71. Jeffery CJ. Mass spectrometry and the search for moonlighting proteins. Mass Spectrom Rev 2005;24:772-782.
72. Carreño FR, Goñi CN, Castro LM et al. 14-3-3 epsilon modulates the stimulated secretion of endopeptidase 24.15. J Neurochem 2005;93:10-25.
73. Seelenmeyer C, Wegehingel S, Tews I et al. Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol 2005;171:373-381.
74. Fujimoto N, Akimoto Y, Suzuki T et al. Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J Endocrinol 2006;190:793-803.
75. 2+-dependent insulin release from the pancreatic beta cell. J Biol Chem 1994;269:6149-6152.
76. Temesvari L, Zhang L, Fodera B et al. Inactivation of lmpA, encoding a LIMPII-related endosomal protein, suppresses the internalization and endosomal trafficking defects in profilin-null mutants. Mol Biol Cell 2000;11:2019-2031.
77. Ravasz E, Somera AL, Mongru DA et al. Hierarchical organization of modularity in metabolic networks. Science 2002;297:1551-1555.
78. Alexander SM, Jackson KJ, Bushnell KM et al. Spatial and temporal expression of the 72-kDa type IV collagenase (MMP-2) correlates with development and differentiation of valves in the embryonic avian heart. Dev Dyn 1997;209:261-268.
79. Brauer PR, Cai DH. Expression of tissue inhibitor of metalloproteinases (TIMPs) during early cardiac development. Mech Dev 2002;113:175-179.
80. Linask KK, Han M, Cai DH et al. Cardiac morphogenesis: Matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of looping. Dev Dyn 2005;233:739-753.
81. Stary M, Pasteiner W, Summer A et al. Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. Exp Cell Res 2005;310:331-343.
82. Mummery CL, Ward D, van den Brink CE et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 2002;200:233-242.
83. Kang YS, Park YG, Kim BK et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 2006;36:377-388.
84. Frossi B, Rivera J, Hirsch E et al. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 2007;178:2549-2555.
85. Butland G, Peregrin-Alvarez JM, Li J et al. Interaction network containing conserved and essential protein complexes in Escherichia coli. Nature 2005;433:531-537.
86. Schadt EE, Lum PY. Systems biology approaches to metabolic and cardiovascular disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J Lipid Res 2006;47:2601-2613.
87. Arrell DK, Niederländer NJ, Perez-Terzic C et al. Embryonic stem cell cardiac differentiation: A proteomic perspective. Adv Mol Med 2006;2:149-156.
88. Arrell DK, Niederländer NJ, Perez-Terzic C et al. Pharmacoproteomics: Advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther 2007;82:316-319.